Quote Originally Posted by Balance View Post
Interesting to note that Aborgen generated revenues of $11.1m in 2010 and loss of $14.2m (as disclosed in the IPO docs at that time) but latest RBC review expect revenues to increase to more than $40m, and for EBITDA to be breakeven.

Here's hoping that operating leverage will kick in and Aborgen starts making profits from 2018 - it has been a long long road for Fletcher shareholders.
Hindered by the 53m employment settlement and the storms that devastated 15' US crop and continued to effect the 16' germination...
There was talk of a land sell down and an end of the heavy development spending.
We should be at the start of a new future. The numbers off seedlings being sold and yet still we're only talking EBITDA break even has me pondering if the value of the product is the biggest hurdle